|
NCRNA00120 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.026000E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.282400E-01 |
| Normal-vs-Stage2 |
3.177600E-01 |
| Normal-vs-Stage3 |
4.536600E-01 |
| Normal-vs-Stage4 |
4.675400E-01 |
| Stage1-vs-Stage2 |
4.860300E-02 |
| Stage1-vs-Stage3 |
2.078800E-01 |
| Stage1-vs-Stage4 |
3.255600E-01 |
| Stage2-vs-Stage3 |
9.300800E-01 |
| Stage2-vs-Stage4 |
7.658600E-01 |
| Stage3-vs-Stage4 |
7.434200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.739200E-01 |
| Normal-vs-AfricanAmerican |
8.941800E-01 |
| Normal-vs-Asian |
1.398020E-01 |
| Caucasian-vs-AfricanAmerican |
7.056800E-01 |
| Caucasian-vs-Asian |
3.194400E-01 |
| AfricanAmerican-vs-Asian |
4.403400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.347000E-01 |
| Normal-vs-Female |
2.201200E-01 |
| Male-vs-Female |
8.862500E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.611600E-01 |
| Normal-vs-Extreme_Weight |
1.268780E-01 |
| Normal-vs-Obese |
2.328400E-01 |
| Normal-vs-Extreme_Obese |
7.287000E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.814400E-01 |
| Normal_Weight-vs-Obese |
7.724400E-02 |
| Normal_Weight-vs-Extreme_Obese |
5.068200E-01 |
| Extreme_Weight-vs-Obese |
1.664250E-02 |
| Extreme_Weight-vs-Extreme_Obese |
4.141800E-01 |
| Obese-vs-Extreme_Obese |
8.711400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.870400E-02 |
| Normal-vs-Age(41-60Yrs) |
8.411800E-01 |
| Normal-vs-Age(61-80Yrs) |
5.964800E-01 |
| Normal-vs-Age(81-100Yrs) |
5.398000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.645800E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.863600E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.036100E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.353200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.195590E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.727700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.972400E-01 |
| Normal-VS-Type2 PRCC |
9.151900E-02 |
| Normal-VS-KIRP CIMP |
1.182310E-03 |
| Normal-VS-Unclassified PRCC |
4.116000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.181760E-01 |
| Type1 PRCC-VS-KIRP CIMP |
9.640400E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
1.746040E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.368900E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
1.332250E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.720080E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.134000E-01 |
| Normal-vs-N1 |
9.849700E-02 |
| Normal-vs-N2 |
5.682000E-01 |
| N0-vs-N1 |
3.580500E-02 |
| N0-vs-N2 |
9.665000E-01 |
| N1-vs-N2 |
3.749000E-01 |
|
|
